Tumor immunology: multidisciplinary science driving basic and clinical advances

Bridget P. Keenan; Elizabeth M. Jaffee; Todd D. Armstrong

doi:10.1158/2326-6066.CIR-13-0011

Tumor immunology: multidisciplinary science driving basic and clinical advances

Bridget P. Keenan, Elizabeth M. Jaffee, Todd D. Armstrong

School of Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

The fourth AACR Special Conference "Tumor Immunology: Basic and Clinical Advances" was held in Miami, FL in December 2012. The overall objective of this meeting was to discuss emerging concepts in cancer immunology and immunotherapy. The key findings that emerged from this meeting included: (i) multiple immune checkpoints should be inhibited to increase effective T-cell therapy, (ii) successful adoptive T-cell therapy will rely on obtaining the proper T-cell phenotype, (iii) chimeric antigen receptors have shown promise in treating some B-cell malignancies, and (iv) multiple pathways of inflammation within the tumor microenvironment are immunotherapy targets.

Original language	English (US)
Pages (from-to)	16-23
Number of pages	8
Journal	Cancer Immunology Research
Volume	1
Issue number	1
DOIs	https://doi.org/10.1158/2326-6066.CIR-13-0011
State	Published - Jul 1 2013

ASJC Scopus subject areas

Immunology
Cancer Research

Access to Document

10.1158/2326-6066.CIR-13-0011

Cite this

@article{f74c7fd5ee664e7e9bb0f3f29325eec5,

title = "Tumor immunology: multidisciplinary science driving basic and clinical advances",

abstract = "The fourth AACR Special Conference {"}Tumor Immunology: Basic and Clinical Advances{"} was held in Miami, FL in December 2012. The overall objective of this meeting was to discuss emerging concepts in cancer immunology and immunotherapy. The key findings that emerged from this meeting included: (i) multiple immune checkpoints should be inhibited to increase effective T-cell therapy, (ii) successful adoptive T-cell therapy will rely on obtaining the proper T-cell phenotype, (iii) chimeric antigen receptors have shown promise in treating some B-cell malignancies, and (iv) multiple pathways of inflammation within the tumor microenvironment are immunotherapy targets.",

author = "Keenan, {Bridget P.} and Jaffee, {Elizabeth M.} and Armstrong, {Todd D.}",

note = "Publisher Copyright: {\textcopyright}2013 AACR.",

year = "2013",

month = jul,

day = "1",

doi = "10.1158/2326-6066.CIR-13-0011",

language = "English (US)",

volume = "1",

pages = "16--23",

journal = "Cancer Immunology Research",

issn = "2326-6066",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

TY - JOUR

T1 - Tumor immunology

T2 - multidisciplinary science driving basic and clinical advances

AU - Keenan, Bridget P.

AU - Jaffee, Elizabeth M.

AU - Armstrong, Todd D.

PY - 2013/7/1

Y1 - 2013/7/1

N2 - The fourth AACR Special Conference "Tumor Immunology: Basic and Clinical Advances" was held in Miami, FL in December 2012. The overall objective of this meeting was to discuss emerging concepts in cancer immunology and immunotherapy. The key findings that emerged from this meeting included: (i) multiple immune checkpoints should be inhibited to increase effective T-cell therapy, (ii) successful adoptive T-cell therapy will rely on obtaining the proper T-cell phenotype, (iii) chimeric antigen receptors have shown promise in treating some B-cell malignancies, and (iv) multiple pathways of inflammation within the tumor microenvironment are immunotherapy targets.

AB - The fourth AACR Special Conference "Tumor Immunology: Basic and Clinical Advances" was held in Miami, FL in December 2012. The overall objective of this meeting was to discuss emerging concepts in cancer immunology and immunotherapy. The key findings that emerged from this meeting included: (i) multiple immune checkpoints should be inhibited to increase effective T-cell therapy, (ii) successful adoptive T-cell therapy will rely on obtaining the proper T-cell phenotype, (iii) chimeric antigen receptors have shown promise in treating some B-cell malignancies, and (iv) multiple pathways of inflammation within the tumor microenvironment are immunotherapy targets.

UR - http://www.scopus.com/inward/record.url?scp=84925226209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925226209&partnerID=8YFLogxK

U2 - 10.1158/2326-6066.CIR-13-0011

DO - 10.1158/2326-6066.CIR-13-0011

M3 - Article

C2 - 24409447

AN - SCOPUS:84925226209

SN - 2326-6066

VL - 1

SP - 16

EP - 23

JO - Cancer Immunology Research

JF - Cancer Immunology Research

IS - 1

ER -

Tumor immunology: multidisciplinary science driving basic and clinical advances

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this